157 related articles for article (PubMed ID: 34875522)
1. Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy.
Turkman N; Liu D; Pirola I
Eur J Med Chem; 2022 Jan; 228():114011. PubMed ID: 34875522
[TBL] [Abstract][Full Text] [Related]
2. High-Contrast PET Imaging with [
Turkman N; Xu S; Huang CH; Eyermann C; Salino J; Khan P
J Med Chem; 2023 Apr; 66(8):5611-5621. PubMed ID: 37068265
[TBL] [Abstract][Full Text] [Related]
3. Novel late-stage radiosynthesis of 5-[18F]-trifluoromethyl-1,2,4-oxadiazole (TFMO) containing molecules for PET imaging.
Turkman N; Liu D; Pirola I
Sci Rep; 2021 May; 11(1):10668. PubMed ID: 34021207
[TBL] [Abstract][Full Text] [Related]
4. Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.
Lobera M; Madauss KP; Pohlhaus DT; Wright QG; Trocha M; Schmidt DR; Baloglu E; Trump RP; Head MS; Hofmann GA; Murray-Thompson M; Schwartz B; Chakravorty S; Wu Z; Mander PK; Kruidenier L; Reid RA; Burkhart W; Turunen BJ; Rong JX; Wagner C; Moyer MB; Wells C; Hong X; Moore JT; Williams JD; Soler D; Ghosh S; Nolan MA
Nat Chem Biol; 2013 May; 9(5):319-25. PubMed ID: 23524983
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.
Bürli RW; Luckhurst CA; Aziz O; Matthews KL; Yates D; Lyons KA; Beconi M; McAllister G; Breccia P; Stott AJ; Penrose SD; Wall M; Lamers M; Leonard P; Müller I; Richardson CM; Jarvis R; Stones L; Hughes S; Wishart G; Haughan AF; O'Connell C; Mead T; McNeil H; Vann J; Mangette J; Maillard M; Beaumont V; Munoz-Sanjuan I; Dominguez C
J Med Chem; 2013 Dec; 56(24):9934-54. PubMed ID: 24261862
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor.
Luckhurst CA; Aziz O; Beaumont V; Bürli RW; Breccia P; Maillard MC; Haughan AF; Lamers M; Leonard P; Matthews KL; Raphy G; Stott AJ; Munoz-Sanjuan I; Thomas B; Wall M; Wishart G; Yates D; Dominguez C
Bioorg Med Chem Lett; 2019 Jan; 29(1):83-88. PubMed ID: 30463802
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.
Seo YJ; Muench L; Reid A; Chen J; Kang Y; Hooker JM; Volkow ND; Fowler JS; Kim SW
Bioorg Med Chem Lett; 2013 Dec; 23(24):6700-5. PubMed ID: 24210501
[TBL] [Abstract][Full Text] [Related]
8. 2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.
Muraglia E; Altamura S; Branca D; Cecchetti O; Ferrigno F; Orsale MV; Palumbi MC; Rowley M; Scarpelli R; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2008 Dec; 18(23):6083-7. PubMed ID: 18930398
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [
Laws MT; Bonomi RE; Kamal S; Gelovani DJ; Llaniguez J; Potukutchi S; Lu X; Mangner T; Gelovani JG
Sci Rep; 2019 Mar; 9(1):3595. PubMed ID: 30837601
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer's Disease.
Chen YA; Lu CH; Ke CC; Chiu SJ; Chang CW; Yang BH; Gelovani JG; Liu RS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445342
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
Zeglis BM; Pillarsetty N; Divilov V; Blasberg RA; Lewis JS
Nucl Med Biol; 2011 Jul; 38(5):683-96. PubMed ID: 21718944
[TBL] [Abstract][Full Text] [Related]
13. Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity.
Zwergel C; Di Bello E; Fioravanti R; Conte M; Nebbioso A; Mazzone R; Brosch G; Mercurio C; Varasi M; Altucci L; Valente S; Mai A
ChemMedChem; 2021 Mar; 16(6):989-999. PubMed ID: 33220015
[TBL] [Abstract][Full Text] [Related]
14. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.
Hsu KC; Liu CY; Lin TE; Hsieh JH; Sung TY; Tseng HJ; Yang JM; Huang WJ
Sci Rep; 2017 Jun; 7(1):3228. PubMed ID: 28607401
[TBL] [Abstract][Full Text] [Related]
15. Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.
Bonomi R; Mukhopadhyay U; Shavrin A; Yeh HH; Majhi A; Dewage SW; Najjar A; Lu X; Cisneros GA; Tong WP; Alauddin MM; Liu RS; Mangner TJ; Turkman N; Gelovani JG
PLoS One; 2015; 10(8):e0133512. PubMed ID: 26244761
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide.
Canzoneri JC; Chen PC; Oyelere AK
Bioorg Med Chem Lett; 2009 Dec; 19(23):6588-90. PubMed ID: 19854643
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity.
Ibrahim TS; Sheha TA; Abo-Dya NE; AlAwadh MA; Alhakamy NA; Abdel-Samii ZK; Panda SS; Abuo-Rahma GEA; Mohamed MFA
Bioorg Chem; 2020 Jun; 99():103797. PubMed ID: 32247939
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors.
Narita K; Matsuhara K; Itoh J; Akiyama Y; Dan S; Yamori T; Ito A; Yoshida M; Katoh T
Eur J Med Chem; 2016 Oct; 121():592-609. PubMed ID: 27318982
[TBL] [Abstract][Full Text] [Related]
20. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
